Phraxis, Inc., a leader in vascular access innovation, announced the successful completion of the first commercial case using the EndoForce Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.

The procedure, performed by Dr. Ari Kramer, Vascular Access Surgeon and early clinical pioneer of EndoForce, took place at Spartanburg Regional Medical Centre in Spartanburg, South Carolina.

EndoForce, recently granted U.S. Food and Drug Administration (FDA) approval, is the first device of its kind designed to simplify vascular access creation by replacing hand-sewn surgical sutures with a precise, reproducible connector. The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial.